We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 1,981 results
  1. Development of a rational framework for the therapeutic efficacy of fecal microbiota transplantation for calf diarrhea treatment

    Background

    Establishing fecal microbiota transplantation (FMT) to prevent multifactorial diarrhea in calves is challenging because of the differences...

    Jahidul Islam, Masae Tanimizu, ... Tomonori Nochi in Microbiome
    Article Open access 21 February 2022
  2. Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments

    Background

    Fecal microbiota transplantation (FMT) and fecal virome transplantation (FVT, sterile filtrated donor feces) have been effective in...

    Torben Sølbeck Rasmussen, **aotian Mao, ... Dennis Sandris Nielsen in Microbiome
    Article Open access 01 July 2024
  3. Gut microbiota restoration through fecal microbiota transplantation: a new atopic dermatitis therapy

    The pathogenesis of atopic dermatitis (AD) involves complex factors, including gut microbiota and immune modulation, which remain poorly understood....

    Jong-Hwa Kim, Kiyoung Kim, Wonyong Kim in Experimental & Molecular Medicine
    Article Open access 20 May 2021
  4. Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD

    Non-alcoholic fatty liver disease (NAFLD) is a multifaceted disease allied with various metabolic disorders, obesity and dysbiosis. Gut microbiota...

    Manisha Gupta, Pawan Krishan, ... Onkar Bedi in Inflammation Research
    Article 01 July 2021
  5. The Efficacy of Fecal Transplantation and Bifidobacterium Supplementation in Ameliorating Propionic Acid-Induced Behavioral and Biochemical Autistic Features in Juvenile Male Rats

    Gut microbiota plays a major role in neurological disorders, including autism. Modulation of the gut microbiota through fecal microbiota...

    Sameera Abuaish, Norah M. Al-Otaibi, ... Afaf El-Ansary in Journal of Molecular Neuroscience
    Article 30 January 2022
  6. Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation

    Neurodegenerative diseases are characterized by neuronal impairment and loss of function, and with the major shared histopathological hallmarks of...

    Hui Wang, Feng Yang, ... Yan Sun in npj Parkinson's Disease
    Article Open access 11 August 2021
  7. Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson’s disease

    Diagnosis of essential tremor (ET) at an early stage can be difficult, especially when distinguishing it from healthy controls (HCs) and Parkinson’s...

    Pei Huang, **chen Zhang, ... Shengdi Chen in npj Parkinson's Disease
    Article Open access 17 July 2023
  8. Effect of fecal microbiota transplantation in patients with slow transit constipation and the relative mechanisms based on the protein digestion and absorption pathway

    Background

    Fecal microbiota transplantation (FMT) is considered an effective treatment for slow transit constipation (STC); nevertheless, the...

    Lulu **e, Chen Xu, ... Yuhong Bian in Journal of Translational Medicine
    Article Open access 01 December 2021
  9. Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease

    Background

    Carbapenem resistant Enterobacteriaceae (CRE) colonization is a risk factor for CRE infection. CRE infection results in an increase in...

    Fangbing Tian, Yin Li, ... Ming Ni in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 29 January 2023
  10. Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes

    Background

    The relationship between the gut mycobiome and end-stage renal disease (ESRD) remains largely unexplored.

    Methods

    In this study, we...

    Yi Ren, Lei Chen, ... Pan Zhang in Journal of Translational Medicine
    Article Open access 25 February 2024
  11. Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis

    Background

    Parkinson’s disease (PD) is a prevalent neurodegenerative disorder, displaying not only well-known motor deficits but also gastrointestinal...

    Zhe Zhao, **gwen Ning, ... Dan Zhang in Microbiome
    Article Open access 17 November 2021
  12. Transplant of fecal microbiota from healthy young mice relieves cognitive defects in late-stage diabetic mice by reducing metabolic disorders and neuroinflammation

    Fecal microbiota transplant (FMT) is becoming as a promising area of interest for treating refractory diseases. In this study, we investigated the...

    **an-xi Ye, Qiao-ying Jiang, ... Hong Zheng in Acta Pharmacologica Sinica
    Article 11 July 2024
  13. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

    Background

    Donor selection is an important factor influencing the engraftment and efficacy of fecal microbiota transplantation (FMT) for complex...

    Brooke C. Wilson, Tommi Vatanen, ... Justin M. O’Sullivan in Microbiome
    Article Open access 13 May 2021
  14. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    Purpose

    We investigated the role of fecal calprotectin (FC) and lactoferrin (FL) as predictive biomarkers in Clostridioides difficile infection (CDI).

    ...
    Mario Ágreda Fernández, Julia Origüen, ... Mario Fernández-Ruiz in European Journal of Clinical Microbiology & Infectious Diseases
    Article 11 December 2023
  15. Engraftment of essential functions through multiple fecal microbiota transplants in chronic antibiotic-resistant pouchitis—a case study using metatranscriptomics

    Background

    Ileal pouch-anal anastomosis (IPAA) is the standard of care after total proctocolectomy for ulcerative colitis (UC). Around 50% of patients...

    Zhi-Luo Deng, Dietmar H. Pieper, ... Irene Wagner-Döbler in Microbiome
    Article Open access 01 December 2023
  16. Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity

    Background

    Chronic kidney disease (CKD) is a severe public health problem associated with a disordered gut microbiome. However, the functional...

    Haichao Wang, Aisima Ainiwaer, ... Huanlong Qin in Microbiome
    Article Open access 09 January 2023
  17. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial

    Fecal microbial transplantation (FMT) from lean donors to patients with obesity has been associated with metabolic benefits, yet results so far have...

    Valentin Mocanu, Zhengxiao Zhang, ... Karen L. Madsen in Nature Medicine
    Article 05 July 2021
  18. Prevotella copri transplantation promotes neurorehabilitation in a mouse model of traumatic brain injury

    Background

    The gut microbiota plays a critical role in regulating brain function through the microbiome-gut-brain axis (MGBA). Dysbiosis of the gut...

    Nina Gu, ** Yan, ... Zhijian Huang in Journal of Neuroinflammation
    Article Open access 04 June 2024
  19. Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine

    Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating inflammatory bowel diseases and irritable bowel syndrome in an...

    Nicolas Benech, Harry Sokol in Genome Medicine
    Article Open access 30 June 2020
  20. Cord Blood Transplantation for Very Early-Onset Inflammatory Bowel Disease Caused by Interleukin-10 Receptor Deficiency

    Purpose

    Interleukin-10 receptor (IL-10R) deficiency can result in life-threatening very early-onset inflammatory bowel disease (VEO-IBD). Umbilical...

    ** Wang, **aowen Qian, ... **aowen Zhai in Journal of Clinical Immunology
    Article 19 February 2024
Did you find what you were looking for? Share feedback.